PLSE

45.5502.57%
MS

Manmeet Singh Soni

COO, CFO & Director

Mr. Manmeet Singh Soni, C.P.A., served as Chief Operating Officer at Reata Pharmaceuticals, Inc since June 01, 2020 and also served as its President since February 7, 2022. He served as Chief Financial Officer of Reata Pharmaceuticals, Inc. until February 7, 2022 and its Executive Vice President since joining in August 28, 2019 and where he was responsible for overall global functions of finance, tax, treasury, internal audit, information technology, investor relations, corporate communication and strategy functions. Mr. Soni served as Lead Independent Director of Summit Therapeutics Inc. since April 2023 until October 13, 2023 and had been its Independent Non-Executive Director since December 24, 2019 until April 2023. He serves as Chief Operating Officer at Summit Therapeutics Inc. since October 13, 2023 and has been its Chief Financial Officer since April 2, 2024 and also serves as its Director since December 24, 2019. He served as an Independent Director of Arena Pharmaceuticals, Inc. since December 17, 2018 until June 2021. He served as Chief Financial Officer of Alnylam Pharmaceuticals, Inc. since May 09, 2017 until August 12, 2019 and served as its Senior Vice President and Principal Accounting Officer since October 9, 2018 until August 12, 2019. He served as the Chief Financial Officer, Executive Vice President and Treasurer at Ariad Pharmaceuticals, Inc. from March 21, 2016 to February 16, 2017. Mr. Soni continued as an employee of ARIAD through May 2017. Mr. Soni served as the Chief Financial Officer of Pharmacyclics Inc. since February 4, 2014 until May 2015 and served as its Principal Accounting Officer from August 2013 to February 2014. Mr. Soni served as Treasurer of Pharmacyclics Inc. since August 16, 2013. He served as Senior Vice President of Finance at Pharmacyclics Inc. since August 2013, served as its Principal Financial Officer and Principal Accounting Officer since August 16, 2013. Mr. Soni served as Vice President and Corporate Controller at Pharmacyclics Inc. since February 2013 and served as its Executive Vice President of Finance until February 4, 2014. He first joined Pharmacyclics in September 2012 as Corporate Controller. Previously, he worked at ZELTIQ Aesthetics where he served as Controller and Senior Director of finance and where he was responsible for accounting, SEC and Treasury functions. He worked at PricewaterhouseCoopers San Jose, in the Life Science and Venture Capital Group, providing audit and assurance services to various public and privately held companies in the pharmaceutical, biotechnology, software and semiconductor space. Prior to that, he worked at PricewaterhouseCoopers India providing audit and assurance services. He serves as Director of Genoscience Pharma. He has been an Independent Director of Pulse Biosciences, Inc. since November 2, 2017 and serves as its Lead Independent Director from March 28, 2023. Mr. Soni has extensive experience in transitioning biotechnology companies from development stage through commercialisation and globalisation. He is a Certified Public Accountant, licensed in the state of California and a Chartered Accountant from India. Mr. Soni received his Bachelor of Commerce from Hansraj College, Delhi University in India.

Positions